Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB
· Real-Time Price · USD
6.07
-0.10 (-1.62%)
At close: Aug 15, 2025, 2:58 PM
-1.62% (1D)
| Bid | 6.06 |
| Market Cap | 472.93M |
| Revenue (ttm) | 3.12M |
| Net Income (ttm) | -139.68M |
| EPS (ttm) | -2.79 |
| PE Ratio (ttm) | -2.18 |
| Forward PE | -2.91 |
| Analyst | Buy |
| Ask | 6.1 |
| Volume | 652,711 |
| Avg. Volume (20D) | 1,619,932 |
| Open | 6.17 |
| Previous Close | 6.17 |
| Day's Range | 6.02 - 6.25 |
| 52-Week Range | 2.41 - 10.37 |
| Beta | 2.44 |
About SLDB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SLDB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SLDB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 days ago
+10.6%
Solid Biosciences shares are trading higher after ...
Unlock content with
Pro Subscription
3 weeks ago
+8.51%
Solid Biosciences shares are trading higher after the company announced it received FDA Fast Track Designation status for SGT-501 gene therapy.
